Genetic Technologies Ltd GENE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/27/22 EDT
1.27quote price arrow up+0.01 (+0.79%)
Volume
38,934
52 week range
0.95 - 5.18
Loading...
  • Open1.30
  • Day High1.32
  • Day Low1.22
  • Prev Close1.26
  • 52 Week High5.18
  • 52 Week High Date06/09/21
  • 52 Week Low0.95
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap19.55M
  • Shares Out15.39M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta2.04
  • YTD % Change-32.45

KEY STATS

  • Open1.30
  • Day High1.32
  • Day Low1.22
  • Prev Close1.26
  • 52 Week High5.18
  • 52 Week High Date06/09/21
  • 52 Week Low0.95
  • 52 Week Low Date05/12/22
  • Market Cap19.55M
  • Shares Out15.39M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta2.04
  • YTD % Change-32.45

RATIOS/PROFITABILITY

  • EPS (TTM)-0.36
  • P/E (TTM)-3.56
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-6.794M
  • ROE (TTM)-40.53%
  • Revenue (TTM)1.53M
  • Gross Margin (TTM)36.29%
  • Net Margin (TTM)-347.26%
  • Debt To Equity (MRQ)0.58%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Genetic Technologies Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Genetic Technologies Limited (GTG) is an Australia-based diversified molecular diagnostics company. The Company is focused on the development and commercialization of genetic risk assessment technology. The Company is engaged in providing genomics-based tests in health, wellness and serious disease through its GeneType and EasyDNA brands. GTG is focused on developing an integrated predictive genetic testing and assessment tools enabling medical practitioners and their...
Peter Rubenstein
Chairman of the Board
Simon Morriss
Chief Executive Officer
Stan Sack
Chief Operating Officer
Michael Tonroe
Chief Financial Officer, Company Secretary
Address
60-66 Hanover St, Fitzroy
Melbourne, VIC
3065
Australia

Top Peers

SYMBOLLASTCHG%CHG
FIXX
Homology Medicines Inc
1.51+0.06+4.14%
PTN
Palatin Technologies Inc
0.3645+0.0145+4.14%
ARDX
Ardelyx Inc
0.6574+0.0423+6.88%
VIRX
Viracta Therapeutics Inc
2.15+0.05+2.38%
OTLC
Oncotelic Therapeutics Inc
0.2325+0.0025+1.09%
MIRO
Miromatrix Medical Inc
3.98+0.21+5.57%